Clinical Trials Insight: 700015023
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2007
At a glance
- Drugs Pumosetrag (Primary)
- Indications Gastro-oesophageal reflux
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Sponsors Dynogen Pharmaceuticals
- 12 Jun 2007 Status changed from in progress.
- 12 Jun 2007 Results have been reported.
- 15 Sep 2006 New trial record.